Pediatrics Doctors in Utah Medicare Details, Address, Contact

963 Pediatrics doctors found. Showing 281 - 300

Miss Frances Y. Liu, D.O. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 34 S 300 E, Provo, UT 84606 Phone: 801-850-9147    Fax: 435-578-0700

Dr. Stuart Wayne Slingerland, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1355 N University Ave, Ste. 210, Provo, UT 84604 Phone: 801-373-8930

Ross Mitchell Adams, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1355 N University Ave, #210, Provo, UT 84604 Phone: 801-373-8930    Fax: 801-377-6811

Joy R Patten, MD Pediatrics - Adolescent Medicine Medicare: Not Enrolled in Medicare Practice Location: 1750 N Wymount Terrace Dr, Provo, UT 84601 Phone: 801-422-2771    Fax: 801-422-0761

Dr. Richard Wesley Later, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1055 N 300 W, #311, Provo, UT 84604 Phone: 801-357-7883    Fax: 801-357-7975

Dr. Jon S Woods, MD Pediatrics - Pediatric Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 1034 N 500 W, Provo, UT 84604 Phone: 801-357-1700

Dr. Monica Child Wonnacott, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 12391 S 4000 W, Riverton, UT 84096 Phone: 801-302-1700    Fax: 801-302-1714

Ms. Katherine Douglas Westmoreland, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 3723 W 12600 S, Ste 450, Riverton, UT 84065 Phone: 801-285-4543    Fax: 801-285-4540

Kristina D Esham, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 3723 W 12600 S, Suite 450, Riverton, UT 84065 Phone: 801-285-4543

Dr. Stasha S Lewis, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 3723 W 12600 S Ste 150, Riverton, UT 84065 Phone: 801-285-4561

Dr. Shellie J Ring, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 3723 W 12600 S Ste 330, Riverton, UT 84065 Phone: 801-285-4543

J Timothy Duffy, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 3723 W 12600 S, Suite 450, Riverton, UT 84065 Phone: 801-285-4543

Dr. Craig Alan Coleby, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 12391 S 4000 W, Suite 100, Riverton, UT 84096 Phone: 801-302-1700

Dr. Marisa Johanna Nagle, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3723 W 12600 S, Suite 450, Riverton, UT 84065 Phone: 801-285-4543

Dr. Sadie M West, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 3723 West 12600 South, Suite 450, Riverton, UT 84065 Phone: 801-285-4540

Jimmy Lynn Ryan, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1288 W 12700 S, Riverton, UT 84065 Phone: 801-253-3500    Fax: 801-253-5859

Monica Hinz, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 12391 S 4000 W, Riverton, UT 84096 Phone: 801-302-1700

Carly Rae Davis, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 12391 S 4000 W, Riverton, UT 84096 Phone: 801-302-1700

Dr. Shannon R Staker, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 210 W 300 N 75-3, Roosevelt, UT 84066 Phone: 435-722-3971    Fax: 435-722-6104

Kyler Black, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 250 W 300 N, Roosevelt, UT 84066 Phone: 435-722-4691

News Archive

Research shows how loss of de-N-glycosylation enzyme causes detrimental effects

Peptide: N-glycanase (NGLY1) is an evolutionarily conserved enzyme for removing N-linked glycans (N-glycans) from glycoproteins and is involved in proteostasis of N-glycoproteins in the cytosol. In 2012, a rare genetic disorder called NGLY1 deficiency was discovered by an exome analysis.

New data on Surfaxin LS presented at 2010 PAS Annual Meeting

Discovery Laboratories, Inc., announced that new data regarding Surfaxin LS (its novel, lyophilized KL4 surfactant dosage form) were presented at the 2010 Pediatric Academic Societies Annual Meeting. The two studies presented demonstrate that Surfaxin LS improves lung function and oxygenation while attenuating lung inflammation in the preterm lamb model of respiratory distress syndrome.

Nektar reports etirinotecan pegol Phase 2 study results in patients with Avastin-refractory high-grade glioma

Nektar Therapeutics announced today new data from an investigator-sponsored Phase 2 study of NKTR-102 (etirinotecan pegol) in patients with Avastin-refractory high-grade glioma conducted at Stanford Cancer Institute under the direction of Lawrence Recht, M.D., Professor of Neurology and Neurosurgery, with co-investigator Seema Nagpal, M.D., Clinical Assistant Professor of Neurology and Neurological Sciences, Stanford School of Medicine.

Research roundup: Less savings needed for retirement health expenses; falls as a predictor of surgical outcomes

Each week, KHN compiles a selection of recently released health policy studies and briefs.

Read more Medical News

› Verified 4 days ago

• «
• 10
• 11
• 12
• 13
• 14
• 15(current)
• 16
• 17
• 18
• 19
• 20
• »